Arctic Bioscience As Stock Current Ratio
| ABS Stock | NOK 1.86 0.08 4.12% |
Arctic Bioscience AS fundamentals help investors to digest information that contributes to Arctic Bioscience's financial success or failures. It also enables traders to predict the movement of Arctic Stock. The fundamental analysis module provides a way to measure Arctic Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arctic Bioscience stock.
Arctic |
Arctic Bioscience AS Company Current Ratio Analysis
Arctic Bioscience's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Arctic Bioscience AS has a Current Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current ratio for all Norway stocks is 100.0% higher than that of the company.
Arctic Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arctic Bioscience's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arctic Bioscience could also be used in its relative valuation, which is a method of valuing Arctic Bioscience by comparing valuation metrics of similar companies.Arctic Bioscience is currently under evaluation in current ratio category among its peers.
Arctic Fundamentals
| Return On Equity | -0.22 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (1.98) % | |||
| Operating Margin | (1.86) % | |||
| Current Valuation | 145.21 M | |||
| Shares Outstanding | 24.38 M | |||
| Shares Owned By Insiders | 55.06 % | |||
| Shares Owned By Institutions | 9.01 % | |||
| Price To Book | 1.05 X | |||
| Price To Sales | 14.73 X | |||
| Revenue | 21.52 M | |||
| Gross Profit | 5.8 M | |||
| EBITDA | (39.72 M) | |||
| Net Income | (42.58 M) | |||
| Book Value Per Share | 13.19 X | |||
| Cash Flow From Operations | (39.49 M) | |||
| Earnings Per Share | (1.75) X | |||
| Target Price | 15.0 | |||
| Number Of Employees | 13 | |||
| Market Capitalization | 276.66 M | |||
| Total Asset | 341.47 M | |||
| Net Asset | 341.47 M |
About Arctic Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arctic Bioscience AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arctic Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arctic Bioscience AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.